These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28044214)

  • 1. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.
    Kakugawa Y; Tada H; Kawai M; Suzuki T; Nishino Y; Kanemura S; Ishida T; Ohuchi N; Minami Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):115-125. PubMed ID: 28044214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol.
    Honma N; Saji S; Hirose M; Horiguchi S; Kuroi K; Hayashi S; Utsumi T; Harada N
    Cancer Sci; 2011 Oct; 102(10):1848-54. PubMed ID: 21707867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of BMI and physical activity to sex hormones in postmenopausal women.
    McTiernan A; Wu L; Chen C; Chlebowski R; Mossavar-Rahmani Y; Modugno F; Perri MG; Stanczyk FZ; Van Horn L; Wang CY;
    Obesity (Silver Spring); 2006 Sep; 14(9):1662-77. PubMed ID: 17030978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
    Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
    Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
    James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sex hormone levels after menopause and subsequent breast cancer.
    Berrino F; Muti P; Micheli A; Bolelli G; Krogh V; Sciajno R; Pisani P; Panico S; Secreto G
    J Natl Cancer Inst; 1996 Mar; 88(5):291-6. PubMed ID: 8614008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer.
    Kakugawa Y; Minami Y; Tateno H; Inoue H; Fujiya T
    Breast Cancer; 2007; 14(3):269-76. PubMed ID: 17690503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
    Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
    J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiposity and sex hormones in postmenopausal breast cancer survivors.
    McTiernan A; Rajan KB; Tworoger SS; Irwin M; Bernstein L; Baumgartner R; Gilliland F; Stanczyk FZ; Yasui Y; Ballard-Barbash R
    J Clin Oncol; 2003 May; 21(10):1961-6. PubMed ID: 12743149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
    Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
    Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
    Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
    Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of intratumoral estrone (E1) and estradiol (E2) in primary breast cancer tissues by sensitive HPLC-RIA].
    Nagaya N; Toi M; Sunahara S; Kurimoto F; Tominaga T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):329-36. PubMed ID: 9051136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.
    Tworoger SS; Rosner BA; Willett WC; Hankinson SE
    Breast Cancer Res; 2011 Oct; 13(5):R99. PubMed ID: 22017816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.
    Secreto G; Meneghini E; Venturelli E; Cogliati P; Agresti R; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
    Int J Biol Markers; 2011; 26(4):241-6. PubMed ID: 22180173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.